While DCG’s 1H18 revenue of $141m and EBITDA of $1.3m did little to excite, the outlook commentary made for good reading. Work in hand and a large pipeline supports a much stronger performance in 2H18 and FY19. A combination of growing revenue and cost control should prove positive for margin in coming periods. We maintain a buy call on the compelling macro environment and an unchanged valuation of $1.40.
To access our review of Decmil please log in under the Client Area Log In at the bottom of this page.
Argonaut’s Client Area allows you to view delayed share prices, access Argonaut’s wealth of Research as well as create custom portfolios and set up company watch lists.
If you would like to access our research please contact us to create an account.
+61 8 9224 6888
+852 3557 4888